Windtree Therapeutics Inc
WINT· OTC
Filed Aug 14, 2012 · 10-Q · 45 days after period end · 0001140361-12-037146
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Net Income | -$7.14M | -$8.08M | -$793.00K |
| EPS Diluted | -$0.16 | -$0.34 | -$0.07 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Windtree Therapeutics Inc · CIK 946486 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 14, 2012 · 45 d after period end